Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-Pd-1 Therapy

Cancer Research - United States
doi 10.1158/0008-5472.can-19-0267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Influence on [18F]FDG Uptake by Cancer Cells After Anti-Pd-1 Therapy in an Enforced-Immune Activated Mouse Tumor

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

Reply to ‘Challenging PD-L1 Expressing Cytotoxic T Cells as a Predictor for Response to Immunotherapy in Melanoma’

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

CD4+ T-Cell Immunity in the Peripheral Blood Correlates With Response to Anti-Pd-1 Therapy

Cancer immunology research
Cancer ResearchImmunology
2019English

Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy

Clinical Cancer Research
Cancer ResearchOncology
2017English

Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells

Clinical Cancer Research
Cancer ResearchOncology
2013English

Transduction of Human Dendritic Cells With Adenovirus Encoding Anti-Pd-1 Reduces PD-1 Expression on Co-Cultured T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells

Journal of Immunology
AllergyImmunology
2009English

Automated Image Analysis of NSCLC Biopsies to Predict Response to Anti-Pd-L1 Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy